GlassScriptPhysician profile
Kevin C Roe
NPI 1538309174
$755.00
in general payments reported to CMS, 2019-2025
16 companies · $173 in 2025
The $173 reported for 2025 was less than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
See the full distribution for Nephrology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $272 · 2020: $17.95 · 2021: $18.26 · 2022: $41.46 · 2023: $113 · 2024: $119 · 2025: $173.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $405.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $404.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $153.02 | 2024-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $80.85 | 2024-2025 | Lokelma, Farxiga |
| Amgen INC. | $76.45 | 2019-2022 | |
| Mallinckrodt Enterprises LLC | $74.99 | 2019 | |
| Novartis Pharmaceuticals Corporation | $67.21 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $57.89 | 2024-2025 | Jynarque |
| Nxstage Medical, INC. | $56.00 | 2019 | |
| Genzyme Corporation | $32.34 | 2023 | |
| Travere Therapeutics, INC. | $27.44 | 2023 | |
| Amarin Pharma, INC. | $22.31 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $22.14 | 2023 | Inpefa |
| Alexion Pharmaceuticals, INC. | $21.75 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $17.95 | 2020 | |
| Fresenius USA Marketing, INC. | $17.65 | 2023 | |
| Merck Sharp & Dohme LLC | $13.64 | 2023 | Verquvo |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $13.37 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Roe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.